Table 2.

Effects on ultrasonographic evaluation

Degree of severity	Abexol (n = 22)		Atorvastatin (n = 23)		Combined therapy (n = 24)		Diet + exercise (n = 23)
	Baseline	24 weeks	Baseline	24 weeks	Baseline	24 weeks	Baseline	24 weeks
Normal	0	2	0	2	0	2	0	6
Mild	5	7	2	6	4	12	7	7
Moderate	11	10	14	12	18	8	12	8
Severe	6	3	7	3	2	2	4	2
	n	%	n	%	n	%	n	%
Patients who remained the same at 24 weeks	10	45.5	12	52.2	11	45.8	12	52.2
Patients with reduction of echogenicity by at least one degree at 24 weeks	10	45.5	11	47.8	11	45.8	11	47.8

n – number of patients

All comparisons were not significant (Fisher probability exact test, p > 0.05)